Publications by Gro Owren Nygaard

32 publications found

  1. Pontillo G, Prados F, Colman J, Kanber B, Abdel-Mannan O, Al-Araji S, Bellenberg B, Bianchi A, Bisecco A, Brownlee WJ, Brunetti A, Cagol A, Calabrese M, Castellaro M, Christensen R, Cocozza S, Colato E, Collorone S, Cortese R, De Stefano N, Enzinger C, Filippi M, Foster MA, Gallo A, Gasperini C et al. (2024)
    Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap
    Neurology, 103 (10), e209976
    DOI 10.1212/WNL.0000000000209976, PubMed 39496109
  2. Nygaard GO, Holmøy T (2024)
    Norwegian health service should offer stem cell therapy for multiple sclerosis
    Tidsskr Nor Laegeforen, 144 (2)
    DOI 10.4045/tidsskr.23.0770, PubMed 38349100
  3. Wolf AS, Ravussin A, König M, Øverås MH, Solum G, Kjønstad IF, Chopra A, Holmøy T, Harbo HF, Syversen SW, Jørgensen KK, Høgestøl EA, Vaage JT, Celius EG, Lund-Johansen F, Munthe LA, Nygaard GO, Mjaaland S (2023)
    T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
    JCI Insight, 8 (12)
    DOI 10.1172/jci.insight.165111, PubMed 37159281
  4. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
    Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 8 (1), 4
    DOI 10.1038/s41541-023-00600-6, PubMed 36697432
  5. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
    Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 7 (1), 174
    DOI 10.1038/s41541-022-00586-7, PubMed 36585405
  6. Nygaard GO, Torgauten H, Skattebøl L, Høgestøl EA, Sowa P, Myhr KM, Torkildsen Ø, Celius EG (2022)
    Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis
    Mult Scler Relat Disord, 62, 103812
    DOI 10.1016/j.msard.2022.103812, PubMed 35462167
  7. Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
    Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
    Br J Haematol, 197 (6), 697-708
    DOI 10.1111/bjh.18149, PubMed 35254660
  8. König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO (2022)
    Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
    JAMA Neurol, 79 (3), 307-309
    DOI 10.1001/jamaneurol.2021.5109, PubMed 35072702
  9. König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
    Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
    J Neurol Neurosurg Psychiatry, 94 (1), 19-22
    DOI 10.1136/jnnp-2021-327612, PubMed 34670844
  10. Høgestøl EA, Ghezzo S, Nygaard GO, Espeseth T, Sowa P, Beyer MK, Harbo HF, Westlye LT, Hulst HE, Alnæs D (2021)
    Functional connectivity in multiple sclerosis modelled as connectome stability: A 5-year follow-up study
    Mult Scler, 28 (4), 532-540
    DOI 10.1177/13524585211030212, PubMed 34259578
  11. Holmøy T, Nygaard GO, Myhr KM, Bø L (2021)
    [Correction: Disease-modifying therapy for multiple sclerosis]
    Tidsskr Nor Laegeforen, 141 (10)
    DOI 10.4045/tidsskr.21.0454, PubMed 34182741
  12. Holmøy T, Nygaard GO, Myhr KM, Bø L (2021)
    Disease-modifying therapy for multiple sclerosis
    Tidsskr Nor Laegeforen, 141 (8)
    DOI 10.4045/tidsskr.21.0155, PubMed 34047171
  13. Brune S, Høgestøl EA, Cengija V, Berg-Hansen P, Sowa P, Nygaard GO, Harbo HF, Beyer MK (2020)
    LesionQuant for Assessment of MRI in Multiple Sclerosis-A Promising Supplement to the Visual Scan Inspection
    Front Neurol, 11, 546744
    DOI 10.3389/fneur.2020.546744, PubMed 33362682
  14. de Rodez Benavent SA, Nygaard GO, Nilsen KB, Etholm L, Sowa P, Wendel-Haga M, Harbo HF, Drolsum L, Laeng B, Kerty E, Celius EG (2019)
    Neurodegenerative Interplay of Cardiovascular Autonomic Dysregulation and the Retina in Early Multiple Sclerosis
    Front Neurol, 10, 507
    DOI 10.3389/fneur.2019.00507, PubMed 31156539
  15. Høgestøl EA, Kaufmann T, Nygaard GO, Beyer MK, Sowa P, Nordvik JE, Kolskår K, Richard G, Andreassen OA, Harbo HF, Westlye LT (2019)
    Cross-Sectional and Longitudinal MRI Brain Scans Reveal Accelerated Brain Aging in Multiple Sclerosis
    Front Neurol, 10, 450
    DOI 10.3389/fneur.2019.00450, PubMed 31114541
  16. Høgestøl EA, Nygaard GO, Alnæs D, Beyer MK, Westlye LT, Harbo HF (2019)
    Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis
    PLoS One, 14 (4), e0210375
    DOI 10.1371/journal.pone.0210375, PubMed 30933977
  17. Lindland ES, Solheim AM, Andreassen S, Quist-Paulsen E, Eikeland R, Ljøstad U, Mygland Å, Elsais A, Nygaard GO, Lorentzen ÅR, Harbo HF, Beyer MK (2018)
    Imaging in Lyme neuroborreliosis
    Insights Imaging, 9 (5), 833-844
    DOI 10.1007/s13244-018-0646-x, PubMed 30187265
  18. Nygaard GO (2017)
    [In-hospital stroke]
    Tidsskr Nor Laegeforen, 137 (19)
    DOI 10.4045/tidsskr.17.0634, PubMed 29043721
  19. de Rodez Benavent SA, Nygaard GO, Harbo HF, Tønnesen S, Sowa P, Landrø NI, Wendel-Haga M, Etholm L, Nilsen KB, Drolsum L, Kerty E, Celius EG, Laeng B (2017)
    Fatigue and cognition: Pupillary responses to problem-solving in early multiple sclerosis patients
    Brain Behav, 7 (7), e00717
    DOI 10.1002/brb3.717, PubMed 28729927
  20. Gustavsen MW, Celius EG, Winsvold BS, Moen SM, Nygaard GO, Berg-Hansen P, Lie BA, Zwart JA, Harbo HF (2016)
    Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study
    Mult Scler J Exp Transl Clin, 2, 2055217316682976
    DOI 10.1177/2055217316682976, PubMed 28607748
  21. Sowa P, Nygaard GO, Bjørnerud A, Celius EG, Harbo HF, Beyer MK (2017)
    Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis
    Neuroradiology, 59 (7), 655-664
    DOI 10.1007/s00234-017-1849-4, PubMed 28585082
  22. Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
    [Not Available]
    Tidsskr Nor Laegeforen, 136 (20), 1702
    DOI 10.4045/tidsskr.16.0865, PubMed 27830899
  23. Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
    [Not Available]
    Tidsskr Nor Laegeforen, 136 (19), 1608
    DOI 10.4045/tidsskr.16.0826, PubMed 27790879
  24. Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK (2016)
    [MRI in multiple sclerosis]
    Tidsskr Nor Laegeforen, 136 (16), 1373-6
    DOI 10.4045/tidsskr.15.1361, PubMed 27637059
  25. Nygaard GO, de Rodez Benavent SA, Harbo HF, Laeng B, Sowa P, Damangir S, Bernhard Nilsen K, Etholm L, Tønnesen S, Kerty E, Drolsum L, Inge Landrø N, Celius EG (2015)
    Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis
    Mult Scler Relat Disord, 4 (6), 585-9
    DOI 10.1016/j.msard.2015.08.003, PubMed 26590666
  26. Sowa P, Bjørnerud A, Nygaard GO, Damangir S, Spulber G, Celius EG, Due-Tønnessen P, Harbo HF, Beyer MK (2015)
    Reduced perfusion in white matter lesions in multiple sclerosis
    Eur J Radiol, 84 (12), 2605-12
    DOI 10.1016/j.ejrad.2015.09.007, PubMed 26391230
  27. Nygaard GO, Celius EG, de Rodez Benavent SA, Sowa P, Gustavsen MW, Fjell AM, Landrø NI, Walhovd KB, Harbo HF (2015)
    A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity
    PLoS One, 10 (8), e0135974
    DOI 10.1371/journal.pone.0135974, PubMed 26280173
  28. Gustavsen MW, Page CM, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Celius EG, Harbo HF (2014)
    Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study
    BMC Neurol, 14, 196
    DOI 10.1186/s12883-014-0196-x, PubMed 25274070
  29. Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF (2014)
    Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis
    Mult Scler, 21 (4), 402-14
    DOI 10.1177/1352458514543811, PubMed 25139946
  30. Gustavsen MW, Celius EG, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Harbo HF (2014)
    No association between multiple sclerosis and periodontitis after adjusting for smoking habits
    Eur J Neurol, 22 (3), 588-90
    DOI 10.1111/ene.12520, PubMed 25041906
  31. Fremeau RT, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bellocchio EE, Fortin D, Storm-Mathisen J, Edwards RH (2001)
    The expression of vesicular glutamate transporters defines two classes of excitatory synapse
    Neuron, 31 (2), 247-60
    DOI 10.1016/s0896-6273(01)00344-0, PubMed 11502256
  32. Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK (2016)
    MRI- investigations in multiple sclerosis
    Tidsskr. Nor. Laegeforen., 136 (16), 1373-1376

 
Scroll to top